Credit Suisse Reiterates Outperform on Mr. Cooper Gr, Maintains $57 Price Target
Credit Suisse analyst Douglas Harter reiterates Mr. Cooper Gr (NASDAQ:COOP) with a Outperform and maintains $57 price target.
Barclays Maintains Equal-Weight on Mr. Cooper Gr, Raises Price Target to $48
Barclays analyst Mark Devries maintains Mr. Cooper Gr (NASDAQ:COOP) with a Equal-Weight and raises the price target from $41 to $48.
Earnings Scheduled For February 10, 2023
Companies Reporting Before The Bell
• Global Payments (NYSE:GPN) is expected to report quarterly earnings at $2.41 per share on revenue of $2.01 billion.
Preview: Mr. Cooper Group’s Earnings
Mr. Cooper Group (NASDAQ:COOP) is set to give its latest quarterly earnings report on Friday, 2023-02-10. Here’s what…
Insiders Selling HP, Electronic Arts And 2 Other Stocks
The Nasdaq index jumped around 2.5% on Thursday. Investors, meanwhile, focused on some notable insider trades.
Boeing, Seagate, Chipotle And Other Big Losers From Wednesday
U.S. stocks closed mostly lower on Wednesday, with the Nasdaq Composite dropping over 200 points. Here is the list of some big stocks recording losses in the previous session.
Mr. Cooper Group Q3 EPS $1.55, Sales $510.00M Beat $408.96M Estimate
Mr. Cooper Group (NASDAQ:COOP) reported quarterly earnings of $1.55 per share. The company reported quarterly sales of $510.00 million which beat the analyst consensus estimate of $408.96 million by 24.71 percent. This
Barclays Maintains Equal-Weight on Mr. Cooper Gr, Lowers Price Target to $40
Barclays analyst Mark Devries maintains Mr. Cooper Gr (NASDAQ:COOP) with a Equal-Weight and lowers the price target from $43 to $40.
Mr. Cooper Group Earnings Perspective: Return On Capital Employed
According to Benzinga Pro, during Q2, Mr. Cooper Group (NASDAQ:COOP) earned $151.00 million, a 77.05% increase from the preceding quarter. Mr. Cooper Group's sales decreased to $599.00 million, a 43.06% change since Q1. Mr.
Why This Healthcare Stock Dipped Over 75%; Here Are 73 Biggest Movers From Yesterday
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 53.2% to close at $3.14 on Wednesday. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital Medical Center for S&P vaccine platform development.